Ads
related to: acute leukemia in adults- Safety
Learn More About Well Characterized
Safety Profile.
- Efficacy
Durable Complete Remissions
for R/R AML Patients.
- Access & Resources
Support is Available for
You and Your Patients.
- Dosing & Monitoring
Twice Daily
Oral Dosing.
- Safety
Search results
Celebrating survivors and research: A beacon of hope for pediatric cancer treatments
Savannah Morning News via Yahoo News· 9 hours agoAs the mother of Cora Garola, witnessing my daughter's diagnosis of acute lymphoblastic leukemia at...
Researchers discover that a type of childhood leukemia originates during fetal development
Medical Xpress· 7 days agoAcute myeloid leukemia is the second most common type of acute leukemia in childhood and can be...
Onureg and dosage: Strengths, form, when to take, and more
Medical News Today· 2 days agoOnureg (azacitidine) is a brand-name drug prescribed to treat acute myeloid leukemia in certain...
Autolus reports promising results for obe-cel in leukemia study By Investing.com
Investing.com· 6 days agoAutolus Therapeutics plc (NASDAQ:AUTL), a biopharmaceutical company focused on T cell therapies for...
Steps To-Marrow: Grandmother walks hundreds of miles to raise donor awareness
The Wenatchee World· 14 hours agoJeana Moore, 71, is not singing “I’m Gonna Be,” but she is walking hundreds of miles, thousands one...
Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
Medical Xpress· 6 days ago(ASCO) Annual Meeting. The novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy...
Autolus shares hold steady with Buy rating on Obe-cel market penetration By Investing.com
Investing.com· 7 days agoOn Thursday, Truist Securities maintained a Buy rating on shares of Autolus Therapeutics Plc...
Cancer Survivors Are Sharing The Weird Symptom That Made Them Go "Hm, Something Isn't Right Here,"...
BuzzFeed via Yahoo News· 5 days ago"If they tell you it might be cancer and have you come back in a couple of weeks for a biopsy, say...
Rgenta Therapeutics Presents Preclinical Data from Lead Program RGT-61159, a Potent Inhibitor of...
The Woonsocket Call· 6 days ago"The data presented at ASCO 2024 demonstrate efficient and specific modulation of the oncogenic transcription factor MYB, a target that historically has been difficult to drug, by RGT-61159 ...
Rydapt dosage: Form, strength, how to take, and more
Medical News Today· 2 days agoYour doctor will determine the best dosage to fit your needs. Doctors may prescribe Rydapt to treat AML in adults with a certain genetic mutation. If...
Ads
related to: acute leukemia in adults